Genome sequencing has been used to determine how much genes influence human characteristics including height and weight, and ...

SAN DIEGO, Oct. 15, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that GeneDx, a leader in genetic testing for rare diseases, is piloting Illumina's emerging constellation mapped ...

At AGBT, customers will present data demonstrating unparalleled scale and sensitivity in research spanning pulmonary fibrosis, prostate cancer, and 3D reconstructions of mouse brains Company expands ...

SAN DIEGO, Oct. 1, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced the launch of BioInsight, a new business within Illumina, developed to meet industry demand for deeper biologic ...

By signing of a memorandum of understanding (MoU) with Illumina, a global leader in sequencing technology, the Department of Science, Technology and Innovation (DSTI) and the South African Medical ...

Illumina Inc. said the Chinese government has lifted a ban on the company selling its DNA sequencing machines inside the ...